Bullseye Biodevices
Hoboken, US · Founded 2024 · Delaware corporation
Bullseye Biodevices develops a multimodal biosensing platform that combines mechanical, electrical, and optical sensing to assess tissue and organ condition in real time. The technology targets medical applications including tumor localization and surgical margin assessment, skin health monitoring, and organ evaluation during surgery, preservation, and transplantation.
Founders & leadership
Bullseye Biodevices was founded in 2024 by Jinho Kim and Donnie Mir.
Reported raises · per SEC filings
Form D private placements$1.3M disclosed across 1 round · 2026
▶$1.3MraisedAug 2026 · 1 investors · BiotechnologyRule 506(b)
- Jinho KimExecutive Officer, Director
- Mohammad MirExecutive Officer, Director
- Offering amount
- $1.3M
- Amount sold
- $1.3M
- First sale
- Jul 2026
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with Bullseye Biodevices for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Bullseye Biodevices do?
- Bullseye Biodevices develops a multimodal biosensing platform that combines mechanical, electrical, and optical sensing to assess tissue and organ condition in real time. The technology targets medical applications including tumor localization and surgical margin assessment, skin health monitoring, and organ evaluation during surgery, preservation, and transplantation.
- Who founded Bullseye Biodevices?
- Bullseye Biodevices was founded by Jinho Kim, Donnie Mir in 2024.
- How much funding has Bullseye Biodevices raised?
- Bullseye Biodevices has disclosed $1.3M raised across 1 round.
- Where is Bullseye Biodevices headquartered?
- Bullseye Biodevices is headquartered in Hoboken, US.